Moneycontrol PRO
HomeNewsOpinionTrump’s tariffs on pharma will hurt both India, US

Trump’s tariffs on pharma will hurt both India, US

If imposed in the immediate future, customers in the US can ask Indian drug suppliers to temporarily absorb new import duties

February 20, 2025 / 08:34 IST
A persistent focus on local manufacturing by the US will leave Indian companies with no choice but to expand production capacities in North America
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts